2015-08-12
Valentin Fulga of Hemostemix joined us at Stem Cells & Regenerative Medicine Congress 2014 to present ‘ Hemostemix : Your cells, our technology’
Download the presentation now to learn about
Advantages of ACP-01
Ischemic heart disease clinical trial results
Diversified development & commercialization opportunities
…and much more!
Get your copy here! To find out more about diversified development and commercialization opportunities from Hemostemix , attend Stem Cells & Regenerative Medicine Congress USA 2015 September 2-3 in Washington, DC.
The post Hemostemix: Your cells, our technology appeared first on Total Biopharma.